BioScrip Inc. (BIOS) Soars 5.2%

BioScrip Inc. (BIOS) Soars 5.2%

BioScrip Inc. (BIOS) had a good day on the market for Monday April 15 as shares jumped 5.2% to close at $1.82. About 2.46 million shares traded hands on 6,533 trades for the day, compared with an average daily volume of n/a shares out of a total float of 128.16 million. After opening the trading day at $1.71, shares of BioScrip Inc. stayed within a range of $1.84 to $1.71.

With today’s gains, BioScrip Inc. now has a market cap of $233.25 million. Shares of BioScrip Inc. have been trading within a range of $4.14 and $1.69 over the last year, and it had a 50-day SMA of $n/a and a 200-day SMA of $n/a.

BioScrip Inc is one of the provider of home infusion services and home care management solutions in the United States. The firm’s home infusion services primarily involve the intravenous administration of medications treating a wide range of acute and chronic conditions, such as infections, nutritional deficiencies, various immunologic and neurologic disorders, cancer, pain and palliative care. It provides a wide array of home infusion products and services to meet the diverse needs of physicians, patients, and payors.

BioScrip Inc. is based out of Denver, CO and has some 2,043 employees. Its CEO is Daniel Greenleaf.

Scroll Up
error: Content is protected !!